Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters via Yahoo News· 4 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 7 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 4 days agoBut the dividend isn't the only thing attractive about this stock. Believe it or not, Pfizer could...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 5 days agoPfizer Pfizer hasn't performed well recently. Despite its important role in developing effective...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 5 days agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 4 days agoPfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Credit - Joe Raedle—Getty Images Taking the COVID-
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 2 days agoDive Brief: Moderna on Monday said a combination flu and COVID-19 shot it’s developing met the goal...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 5 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 7 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 6 days agoThis approval represents a significant development in the field and is likely to encourage the use...